Solaredge Technologies Inc vs Tenet Healthcare Corporation — how do they compare? Solaredge Technologies Inc trades at $32.8 (market cap $2.00B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 10.5× Solaredge Technologies Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Solaredge Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Solaredge Technologies Inc for 34 Days and Tenet Healthcare Corporation for 15 Days on average.
| SEDG | THC | |
|---|---|---|
Market Cap | $2.00B | $20.98B |
Volume | 2,739,860 | 428,008 |
Sector | Energy | Health |
52-Week High | $78.51 | $280.77 |
52-Week Low | $28.47 | $161.37 |
Typical Hold Time | 34 Days | 15 Days |
Enterprise Value | $1.86B | $32.06B |
Signals from Pluang's Aura AI — not financial advice
SolarEdge Technologies (SEDG) trades at $33.16, down 2.59% with bearish technical signals and mixed fundamentals. The company shows revenue recovery to $1.18B in 2025 but continues posting significant losses with a -20.29% net margin. Recent news highlights legal investigations and AI data center initiatives, while analyst sentiment remains cautious with a $37.75 consensus target.
The outlook remains challenging with persistent profitability issues and legal overhangs, though the AI data center expansion offers long-term potential. Key risks include ongoing losses, high debt levels, and solar industry headwinds. The stock presents speculative appeal for investors betting on a turnaround, but requires careful risk assessment given the current financial strain.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →